177 related articles for article (PubMed ID: 28752960)
1. After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.
El Kassas M; Alboraie M; Mostafa A; Ezzat R; El Tahan A; Afify S; Sweedy A; Kabbash I; Esmat G
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28752960
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
3. The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.
Gordon SC; Fang JW; Silverman AL; McHutchison JG; Albrecht JK
Hepatology; 2000 Aug; 32(2):400-4. PubMed ID: 10915749
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of the serum alanine aminotransferase upper normal limit in chronic hepatitis C patients.
Yagura M; Tanaka A; Kamitsukasa H; Otsuka H; Kanno S; Aoyama T
Intern Med; 2010; 49(6):525-8. PubMed ID: 20228585
[TBL] [Abstract][Full Text] [Related]
5. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
[TBL] [Abstract][Full Text] [Related]
6. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Wu Z; Dong X; Wang G; Zhao H;
J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
[TBL] [Abstract][Full Text] [Related]
7. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
[TBL] [Abstract][Full Text] [Related]
8. Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.
Serper M; Forde KA; Kaplan DE
J Viral Hepat; 2018 Feb; 25(2):187-197. PubMed ID: 28845882
[TBL] [Abstract][Full Text] [Related]
9. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.
Piton A; Poynard T; Imbert-Bismut F; Khalil L; Delattre J; Pelissier E; Sansonetti N; Opolon P
Hepatology; 1998 May; 27(5):1213-9. PubMed ID: 9581673
[TBL] [Abstract][Full Text] [Related]
11. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
[TBL] [Abstract][Full Text] [Related]
12. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
Kim SU; Kim DY; Park JY; Lee JH; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Choi EH; Song KJ; Park YN; Han KH
J Clin Gastroenterol; 2010 Jan; 44(1):66-71. PubMed ID: 19609218
[TBL] [Abstract][Full Text] [Related]
13. Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals.
Kono M; Nishida N; Hagiwara S; Minami T; Chishina H; Arizumi T; Minaga K; Kamata K; Komeda Y; Sakurai T; Takenaka M; Takita M; Yada N; Ida H; Minami Y; Ueshima K; Watanabe T; Kudo M
Dig Dis; 2017; 35(6):556-564. PubMed ID: 29040988
[TBL] [Abstract][Full Text] [Related]
14. Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT.
Al-Ali J; Siddique I; Varghese R; Hasan F
Ann Hepatol; 2012; 11(2):186-93. PubMed ID: 22345335
[TBL] [Abstract][Full Text] [Related]
15. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B.
Hung KY; Lee KC; Yen CJ; Wu KD; Tsai TJ; Chen WY
Nephrol Dial Transplant; 1997 Jan; 12(1):180-3. PubMed ID: 9157333
[TBL] [Abstract][Full Text] [Related]
16. [Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-
Xiao Z; Zhou F; Zhou B; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):150-155. PubMed ID: 30890501
[TBL] [Abstract][Full Text] [Related]
17. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
[TBL] [Abstract][Full Text] [Related]
18. Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.
Sinn DH; Gwak GY; Shin JU; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
World J Gastroenterol; 2013; 19(14):2256-61. PubMed ID: 23599653
[TBL] [Abstract][Full Text] [Related]
19. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
Blatt LM; Tong MJ; McHutchison JG; Russell J; Schmid P; Conrad A
J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
[TBL] [Abstract][Full Text] [Related]
20. Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
Basso M; Giannini EG; Torre F; Blanchi S; Savarino V; Picciotto A
Hepatology; 2009 May; 49(5):1442-8. PubMed ID: 19350657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
